NCT04742959 Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT04742361 Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer Status COMPLETED Phase PHASE3
NCT04736108 Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate Status UNKNOWN Phase PHASE2
NCT04733768 18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer Status COMPLETED Phase PHASE2
NCT04732156 Detection of ISUP≥2 Prostate Cancers Using Multiparametric MRI: Prospective Multicenter Comparison of the PI-RADS Score and an Artificial Intelligence System Status RECRUITING Phase NA
NCT04731844 Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer Status COMPLETED Phase PHASE2
NCT04729114 A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer Status RECRUITING Phase PHASE1
NCT04727736 18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancer Status TERMINATED Phase PHASE2
NCT04724577 12 Fractions Carbon Ion Radiotherapy for Localized Prostate Cancer Status UNKNOWN Phase NA
NCT04718987 Potency pReservation In Prostate cAncer Patients Treated With UltraSound-guided Low-dose Rate Brachytherapy Status RECRUITING Phase NA
NCT04705038 Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments Status COMPLETED Phase NA
NCT04704804 Feasibility of MRI Workflow Alone in External Radiotherapy for the Treatment of Brain and Prostate Tumors Status COMPLETED Phase N/A
NCT04702633 Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer Status COMPLETED Phase N/A
NCT04701021 TENDU Vaccine in Patients With Relapse After Primary Radical Prostatectomy Status COMPLETED Phase PHASE1
NCT04700332 PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer Status RECRUITING Phase PHASE2
NCT04698564 Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging Status RECRUITING Phase PHASE2